The historical data trend for Tilray Brands's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:TLRY vs AQST, EOLS, NIKA: Buyback Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Tilray Brands's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tilray Brands (TSX:TLRY) has a Buyback Yield % of -16.53 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #251 out of 292 companies in the Drug Manufacturers industry, placing it in the top 86%.
Is Tilray Brands' Buyback Yield % too high?
Tilray Brands' current Buyback Yield % is -16.53. Based on the distribution chart, Tilray Brands ranks #251 out of 292 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tilray Brands has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Buyback Yield % compare to AQST and EOLS?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #251 out of 292 companies for Buyback Yield %. This places Tilray Brands in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Tilray Brands and its competitors. Tilray Brands's current Buyback Yield % is -16.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.54, compared to a current price of C$6.52 — trading 62.8% below its estimated fair value. The current Buyback Yield % is -16.53. Tilray Brands' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current Buyback Yield % is -16.53 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (TSX:TLRY) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of C$6.52 is trading 62.8% below its estimated GF Value™ of C$17.54.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for TSX:TLRY:
Buyback Yield %: -16.53
GF Value™: C$17.54 vs. price of C$6.52 (62.8% below fair value)
No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
61GF Score
Get the complete analysis for TSX:TLRY
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:TLRY has been successfully added to your 
